Sort
78,016 grants matching “breast cancer”
Overcoming vaccine-associated hypoxia with advanced biomaterials to enhance cancer immunotherapy
$441,967Stephen Matthew Hatfield · Northeastern University · R01 · FY2024 · EB
Integrating Epigenomic and Nuclear Receptor Signaling in Castrate Resistant Prostate Cancer
$441,943Debabrata Chakravarti · Northwestern University At Chicago · R01 · FY2017 · CA
Integrating Epigenomic and Nuclear Receptor Signaling in Castrate Resistant Prostate Cancer
$441,943Debabrata Chakravarti · Northwestern University At Chicago · R01 · FY2016 · CA
Integrating Epigenomic and Nuclear Receptor Signaling in Castrate Resistant Prostate Cancer
$441,943Debabrata Chakravarti · Northwestern University At Chicago · R01 · FY2015 · CA
VIRTUAL DIALOGUE METHOD FOR PATIENT EDUCATION
$441,897Interactive Drama, Inc. · R44 · FY2002 · NR
Identifying the pro-metastatic mechanisms of neutrophil extracellular traps
$441,891Mikala Egeblad · Johns Hopkins University · R01 · FY2024 · CA
Monitoring neoadjuvant chemotherapy of breast cancer using 3D subharmonic aided pressure estimation
$441,876Kibo Nam · Thomas Jefferson University · R37 · FY2024 · CA
NETS in thrombosis and inflammatory responses
$441,875Denisa D Wagner · Boston Children'S Hospital · R01 · FY2015 · HL
Nanotechnology for targeted therapy and fundamental understanding oftherapeutic resistance in triple negative breast cancer
$441,858Xiaoming He · Univ Of Maryland, College Park · R01 · FY2023 · CA
BIODEGRADABLE NANOPARTICLE FORMULATED TAXOL FOR TARGETED THERAPY OF HEAD AND NECK
$441,856Shuming Nie · Emory University · P50 · FY2009 · CA
Project 2: Targeted Therapies for Malignant Peripheral Nerve Sheath Tumors
$441,855Stephen X Skapek · Indiana University Indianapolis · U54 · FY2017 · CA
Enhancing Tumor Antigen Presentation with Complement Targeted Nanoparticles
$441,796Max Peter Kullberg · University Of Alaska Anchorage · R15 · FY2022 · CA
Development and validation of clinical prediction models for the use and interpretation of multigene hereditary cancer risk assessment
$441,779Sapna Syngal · Dana-Farber Cancer Inst · R01 · FY2019 · CA
LOW FAT DIET AND BREAST CANCER RECURRENCE--OUTCOME TRIAL
$441,722La Biomed Res Inst/ Harbor Ucla Med Ctr · R01 · FY2004 · CA
Targeting ER+ Breast Cancer Through Induced Viral Mimicry
$441,716Charles H Spruck · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2022 · CA
Role of StAR-related lipid transfer protein 10 in alcohol-induced breast cancer progression
$441,680Maria Lauda Tomasi · Cedars-Sinai Medical Center · R01 · FY2024 · AA
Clinical Protocol and Data Management
$441,633Dennis J Slamon · University Of California Los Angeles · P30 · FY2020 · CA
Nanotechnology for targeted therapy and fundamental understanding oftherapeutic resistance in triple negative breast cancer
$441,579Xiaoming He · Univ Of Maryland, College Park · R01 · FY2022 · CA
Improving the Estimation and Communication of Ovarian Cancer Risk Among BRCA1/2 C
$441,569Mary Beryl Daly · Fox Chase Cancer Center · P50 · FY2010 · CA
RESEARCH CORE
$441,565George Stancel · University Of Tx Md Anderson Can Ctr · P60 · FY2008 · MD
Targeting vulnerabilities in copper metabolism in the development of cancer therapies
$441,538Michael J Petris · University Of Missouri-Columbia · R01 · FY2024 · CA
Role of TbRIII in Regulating Motility and Invasion
$441,531Gerard C Blobe · Duke University · R01 · FY2010 · CA
Cancer Control Research Training Curriculum
$441,513Gary R Morrow · University Of Rochester · R25 · FY2010 · CA
Regulation of tumor-infiltrating T cells by macrophages
$441,506Xiaopei Huang · Ohio State University · R01 · FY2025 · CA
Glycomics Laboratory for the Early Detection of Epithelial Ovarian Cancer
$441,461Karen L. Abbott · Univ Of Arkansas For Med Scis · U01 · FY2015 · CA